CHGG vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

CHGG

41.7
AI Score
VS
UTI Wins

UTI

45.4
AI Score

Investment Advisor Scores

CHGG

42score
Recommendation
HOLD

UTI

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CHGG UTI Winner
Revenue 115.11M 661.15M UTI
Net Income -2.72M 15.54M UTI
Net Margin -2.4% 2.4% UTI
Operating Income -4.21M 19.27M UTI
ROE -2.3% 4.5% UTI
ROA -1.2% 1.7% UTI
Total Assets 227.63M 897.86M UTI
Cash 44.62M 130.06M UTI
Current Ratio 1.17 1.30 UTI
Free Cash Flow 9.46M -63.50M CHGG

Relative Price Performance (Last 90 Days)

CHGG 1M: -10.6% · 3M: -31.2% UTI 1M: +1.9% · 3M: -46.2%

Current Technical Phase

CHGG

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.3%), weak momentum, RSI 40

RSI (14): 39.6 · Price: $0.67

UTI

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -24.3%) with fading momentum, RSI 48

RSI (14): 48.4 · Price: $20.80

Fundamentals Snapshot

Metric CHGG UTI
Market Cap — —
Forward P/E -9.6 28.3
Trailing P/E — 33.8
Revenue (TTM) — —
Revenue Growth -0.5% 0.1%
Gross Margin 0.6% 0.6%
Operating Margin -0.1% 0.0%
EPS -0.48 0.61
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.